Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy

Animal studies have suggested that Erythropoiesis-Stimulating Agents (ESAs) may increase vascular endothelial growth factor (VEGF)-related retinopathies, but this effect is unclear in humans. This study evaluates the risk of vision-threatening diabetic retinopathy (VTDR), defined as either diabetic...

Full description

Saved in:

Bibliographic Details
Published in:	Ophthalmic epidemiology Vol. ahead-of-print; no. ahead-of-print; pp. 1 - 9
Main Authors:	Tsui, Jonathan C., Willett, Keirnan, Cohen, Jordana B., Yu, Yinxi, VanderBeek, Brian L.
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis 01-06-2024
Subjects:	Aged Aged, 80 and over Diabetic macular edema Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Diabetic Retinopathy - epidemiology Erythropoiesis-Stimulating Agents Female Hematinics - administration & dosage Hematinics - adverse effects Hematinics - therapeutic use Humans Incidence Macular Edema - drug therapy Macular Edema - epidemiology Macular Edema - etiology Male Middle Aged proliferative diabetic retinopathy Retrospective Studies Risk Factors United States - epidemiology Vision threatening diabetic retinopathy United States Erythropoiesis-Stimulating Agents proliferative diabetic retinopathy Vision threatening diabetic retinopathy Diabetic macular edema
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!